Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1934 1
1947 1
1948 1
1949 1
1950 2
1951 2
1952 2
1953 3
1954 1
1955 1
1956 1
1959 1
1960 1
1962 2
1964 2
1965 1
1966 3
1967 4
1968 2
1969 2
1970 1
1971 3
1972 5
1973 6
1974 3
1975 4
1976 1
1977 2
1978 2
1979 6
1980 3
1981 4
1982 2
1983 5
1984 2
1985 2
1986 4
1987 1
1988 3
1989 5
1990 5
1991 2
1992 2
1993 4
1994 7
1995 9
1996 10
1997 8
1998 11
1999 13
2000 8
2001 17
2002 20
2003 14
2004 15
2005 23
2006 22
2007 25
2008 29
2009 31
2010 24
2011 20
2012 26
2013 25
2014 30
2015 37
2016 41
2017 35
2018 38
2019 58
2020 58
2021 67
2022 66
2023 56
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

885 results

Results by year

Filters applied: . Clear all
Page 1
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer.
Park MD, Reyes-Torres I, LeBerichel J, Hamon P, LaMarche NM, Hegde S, Belabed M, Troncoso L, Grout JA, Magen A, Humblin E, Nair A, Molgora M, Hou J, Newman JH, Farkas AM, Leader AM, Dawson T, D'Souza D, Hamel S, Sanchez-Paulete AR, Maier B, Bhardwaj N, Martin JC, Kamphorst AO, Kenigsberg E, Casanova-Acebes M, Horowitz A, Brown BD, De Andrade LF, Colonna M, Marron TU, Merad M. Park MD, et al. Among authors: farkas am. Nat Immunol. 2023 May;24(5):792-801. doi: 10.1038/s41590-023-01475-4. Epub 2023 Apr 20. Nat Immunol. 2023. PMID: 37081148
Treatment of Benign Prostatic Hyperplasia by Natural Drugs.
Csikós E, Horváth A, Ács K, Papp N, Balázs VL, Dolenc MS, Kenda M, Kočevar Glavač N, Nagy M, Protti M, Mercolini L, Horváth G, Farkas Á, On Behalf Of The Oemonom. Csikós E, et al. Among authors: farkas a. Molecules. 2021 Nov 25;26(23):7141. doi: 10.3390/molecules26237141. Molecules. 2021. PMID: 34885733 Free PMC article. Review.
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases. Roberts JA, et al. Among authors: farkas a. Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Lancet Infect Dis. 2014. PMID: 24768475 Free PMC article. Review.
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.
Salomé B, Sfakianos JP, Ranti D, Daza J, Bieber C, Charap A, Hammer C, Banchereau R, Farkas AM, Ruan DF, Izadmehr S, Geanon D, Kelly G, de Real RM, Lee B, Beaumont KG, Shroff S, Wang YA, Wang YC, Thin TH, Garcia-Barros M, Hegewisch-Solloa E, Mace EM, Wang L, O'Donnell T, Chowell D, Fernandez-Rodriguez R, Skobe M, Taylor N, Kim-Schulze S, Sebra RP, Palmer D, Clancy-Thompson E, Hammond S, Kamphorst AO, Malmberg KJ, Marcenaro E, Romero P, Brody R, Viard M, Yuki Y, Martin M, Carrington M, Mehrazin R, Wiklund P, Mellman I, Mariathasan S, Zhu J, Galsky MD, Bhardwaj N, Horowitz A. Salomé B, et al. Among authors: farkas am. Cancer Cell. 2022 Sep 12;40(9):1027-1043.e9. doi: 10.1016/j.ccell.2022.08.005. Cancer Cell. 2022. PMID: 36099881 Free PMC article.
XXtra killer cells.
Reid Cahn A, Farkas AM. Reid Cahn A, et al. Among authors: farkas am. Nat Rev Immunol. 2022 Sep;22(9):532. doi: 10.1038/s41577-022-00766-5. Nat Rev Immunol. 2022. PMID: 35869322 No abstract available.
Breast Cancer Screening and Prevention.
Farkas AH, Nattinger AB. Farkas AH, et al. Ann Intern Med. 2023 Nov;176(11):ITC161-ITC176. doi: 10.7326/AITC202311210. Epub 2023 Nov 14. Ann Intern Med. 2023. PMID: 37956433 Review.
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing.
Wang L, Sfakianos JP, Beaumont KG, Akturk G, Horowitz A, Sebra RP, Farkas AM, Gnjatic S, Hake A, Izadmehr S, Wiklund P, Oh WK, Szabo PM, Wind-Rotolo M, Unsal-Kacmaz K, Yao X, Schadt E, Sharma P, Bhardwaj N, Zhu J, Galsky MD. Wang L, et al. Among authors: farkas am. Clin Cancer Res. 2021 Aug 1;27(15):4287-4300. doi: 10.1158/1078-0432.CCR-20-4574. Epub 2021 Apr 9. Clin Cancer Res. 2021. PMID: 33837006 Free PMC article.
Epithelial adhesive junctions.
Capaldo CT, Farkas AE, Nusrat A. Capaldo CT, et al. Among authors: farkas ae. F1000Prime Rep. 2014 Jan 2;6:1. doi: 10.12703/P6-1. eCollection 2014. F1000Prime Rep. 2014. PMID: 24592313 Free PMC article. Review.
The natural history of Get3-like chaperones.
Farkas Á, De Laurentiis EI, Schwappach B. Farkas Á, et al. Traffic. 2019 May;20(5):311-324. doi: 10.1111/tra.12643. Traffic. 2019. PMID: 30972921 Free PMC article. Review.
[Splenogonadal fusion in an infant].
Rónaky R, Buzogány M, Farkas A. Rónaky R, et al. Among authors: farkas a. Orv Hetil. 2022 Feb 13;163(7):288-290. doi: 10.1556/650.2022.32315. Print 2022 Feb 13. Orv Hetil. 2022. PMID: 35152207 Hungarian.
885 results